The three described specific aims and approach to their accomplishment in this proposal are: 1) to determine the importance of opioid-receptor interaction on homeostatic cellular renewal of the diabetic corneal epithelium by studying OGF/receptor expression and the effects of excess OGF or blockade of OGF activity with naltrexone on DNA synthesis in diabetic rat corneal epithelium limbus and conjunctiva; 2) to define the role of an endogenous opioid system related to growth in the re-epithelialization of denuded corneal epithelium in diabetic rats by examining healing and integrity of the repaired epithelium after systemic and topical treatment with naltrexone of rats subjected to corneal abrasions; and 3) to ascertain the influence of an endogenous opioid system related to growth in the repair of corneal wound healing by studying the effect of opioid receptor blockade on healing of wounded epithelium in human corneas in organ culture.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21EY013086-02
Application #
6179246
Study Section
Special Emphasis Panel (ZRG1-END (01))
Program Officer
Fisher, Richard S
Project Start
1999-09-30
Project End
2002-09-29
Budget Start
2000-09-30
Budget End
2002-09-29
Support Year
2
Fiscal Year
2000
Total Cost
$195,765
Indirect Cost
Name
Pennsylvania State University
Department
Neurosciences
Type
Schools of Medicine
DUNS #
129348186
City
Hershey
State
PA
Country
United States
Zip Code
17033
McLaughlin, Patricia J; Sassani, Joseph W; Klocek, Matthew S et al. (2010) Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review. Brain Res Bull 81:236-47
Zagon, Ian S; Jenkins, Joe B; Sassani, Joseph W et al. (2002) Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat. Diabetes 51:3055-62
Zagon, Ian S; Verderame, Michael F; McLaughlin, Patricia J (2002) The biology of the opioid growth factor receptor (OGFr). Brain Res Brain Res Rev 38:351-76